The stripping of the legislation from the short-term funding package was described as a "missed opportunity" by the National ...

Ionis Pharma's olezarsen has become the first FDA-approved drug therapy for adults with familial chylomicronaemia syndrome ...

Novo Nordisk and Eli Lilly are currently a duopoly in the obesity market, which reached a value of $24 billion last year ...

Eli Lilly's Zepbound has become the first drug to be FDA-approved for obstructive sleep apnoea (OSA), a sleep-related ...

Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been ...

Dermatology specialist Galderma has claimed a second FDA approval for IL-31 inhibitor Nemluvio, adding atopic dermatitis to ...

The 2022 Inflation Reduction Act (IRA) has introduced significant challenges for the pharmaceutical industry, altering the ...

First-degree murder charges are applied when there is suspicion of premeditated, intentional killing, while second-degree ...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Luca Quagliata, Vice President and Global Head of ...

China is the fourth major market where Kisunla has been approved after the US, Japan, and GB. It gets the green light there ...

What Makes hubXchange’s Roundtable Series Unique? Intimate, Senior-Level Roundtable Discussions: Engage with C-level ...

While Neuralink has been grabbing headlines due to its association with controversial billionaire Musk, other companies - ...